APIMEDS PHARMACEUTICALS US I (APUS) Stock Technical Analysis
NYSEARCA:APUS • US03771D1028
Taking everything into account, APUS scores 0 out of 10 in our technical rating. APUS's overall performance in the market is below average. Also recent evolutions are not that positive. Both the medium and short term picture give negative signs.
- 100% of all other stocks performed better in the past year than APUS.
- APUS is part of the Biotechnology industry. There are 521 other stocks in this industry, of which 93% are performing better than APUS.
- In the last month APUS has a been trading in the 0.95 - 3.00 range, which is quite wide. It is currently trading near the lows of this range.
- The long term trend is neutral, but the short term trend is negative. Better to stay away from this!
- Volume is considerably higher in the last couple of days.
The technical rating of APUS is bad and it also does not present a quality setup at the moment. Price movement has been a little bit too volatile to find a nice entry and exit point. It is probably a good idea to wait for a consolidation first.
More info and screens
1.38
3 important resistance areas can be observed.
- Resistance @1.56 from a horizontal line in the daily time frame.
- A resistance zone ranging from 1.75 to 1.77. This zone is formed by a combination of multiple trend lines and important moving averages in the weekly time frame.
- Resistance @1.81 from a trend line in the daily time frame.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | NEUTRAL | NEUTRAL | The long term trend for APUS is neutral. |
| ChartMill Short Term Trend Indicator | DOWN | NEGATIVE | The short term trend for APUS is down. |
| ChartMill Relative Strength | 0 | NEGATIVE | APUS has a low relative strength, it was outperformed by 100% off all stocks on the market. |
| Simple Moving Average/SMA (20) | DOWN | NEGATIVE | The current price of APUS is below a declining SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of APUS is below a declining SMA(50). |
| Relative Strength Index/RSI (14) | 44.88 | NEUTRAL | The RSI value for APUS is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | -0.01 | NEGATIVE | The MACD value suggests APUS has a negative trend, although the MACD value is rising. |
| Stochastics (14,3) | 42.01 | NEUTRAL | The Stochastics value for APUS is a neutral value. |
| Average True Range in percent/ATR (20) | 22.15 | HIGH VOLATILITY | The high ATR as a percentage value for APUS suggests high volalility. |
| Average Directional Index/ADX (14) | 23.8 | NEUTRAL | The ADX value for APUS suggests a possible start of a new trend. |
1.39
-0.16 (-10.32%)
APIMEDS PHARMACEUTICALS US I / APUS FAQ
What is the ChartMill technical rating of APIMEDS PHARMACEUTICALS US I (APUS) stock?
ChartMill assigns a technical rating of 0 / 10 to APUS.
What is the current trend direction of APIMEDS PHARMACEUTICALS US I (APUS) stock?
The current trend direction for APIMEDS PHARMACEUTICALS US I (APUS) is Bearish.
What is the RSI signal for APUS stock?
APIMEDS PHARMACEUTICALS US I (APUS) has an RSI value of 44.8758. This indicates that the stock is currently neutral.
Can you provide the short term momentum for APIMEDS PHARMACEUTICALS US I?
The short term momentum for APIMEDS PHARMACEUTICALS US I (APUS) is negative.